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Abstract
In animal models, allopregnanolone (ALLO) negatively modulates the hypothalamic-pituitary-
adrenal (HPA) axis and has been shown to exert analgesic effects. The purpose of this study was to
assess the relationship between plasma ALLO immunoreactivity (ALLO-ir), HPA-axis measures,
and pain sensitivity in humans. Forty-five African Americans (21 men, 24 women) and 39 non-
Hispanic Whites (20 men, 19 women) were tested for pain sensitivity to tourniquet ischemia, thermal
heat, and cold pressor tests. Plasma ALLO-ir, cortisol, and β-endorphin concentrations were taken
following an extended rest period. Lower concentrations of ALLO-ir were associated with increased
pain tolerance to all three pain tests and increased pain threshold to the thermal heat pain task in the
non-Hispanic Whites only (rs = -.35 to -.49, ps < .05). Also, only in the non-Hispanic Whites was
cortisol associated with thermal heat tolerance (r = +.39, p<.05) and threshold (r = +.50, p < .01) and
cold pressor tolerance (r = +.32, p < .05), and was β-endorphin concentrations associated with cold
pressor tolerance (r = +.33, p<.05). Mediational analyses revealed that higher cortisol levels mediated
the relationship between lower ALLO-ir and increased thermal heat pain threshold in the non-
Hispanic Whites only. These results suggest that lower ALLO-ir concentrations are associated with
decreased pain sensitivity in humans, especially in non-Hispanic Whites, and that this relationship
may be mediated by HPA-axis function.
INTRODUCTION
African Americans experience more clinical pain (Edwards et al. 2001a;McCracken et al.
2001;Riley et al. 2002) and report more pain associated with chronic medical conditions
(Edwards et al. 2001b). In the laboratory, studies consistently indicate no ethnic differences in
pain onset (i.e. pain threshold) but that African Americans have reduced pain tolerance relative
to Caucasians (Chapman & Jones 1944;Woodrow et al. 1972;Edwards & Fillingim
1999;Sheffield et al. 2000;Campbell et al. 2005;Mechlin et al. 2005). Studies of biological
mechanisms that may contribute to these ethnic differences are scant (Mechlin et al. 2005).
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While there is a well-documented relationship between higher blood pressure (BP) levels and
reduced pain sensitivity in Caucasians (Zamir & Shuber 1980;Maixner 1991;Sheps et al.,
1992;McCubbin & Bruehl 1994;Bragdon et al., 1997), thought to be mediated by stimulation
of mechanoreceptive afferents (i.e., baroreceptors; Randich & Maixner, 1986), a recent report
from our laboratory found no evidence for a relationship between BP and pain sensitivity in
African Americans, while the expected relationship held for a primarily Caucasian sample
(Mechlin et al. 2005). Greater concentrations of stress-induced cortisol are also associated with
decreased pain sensitivity in Caucasian samples (al’Absi et al., 2002;Girdler et al.,
2005;Mechlin et al., 2005). However, our prior study found no evidence for a relationship
involving cortisol and pain sensitivity in African Americans, which was documented in the
primarily Caucasian sample (Mechlin et al. 2005).
Taken together, the results of our previous study suggest ethnic differences in the relationship
of stress-responsive biological measures, that may act to diminish pain as part of an integrated
response during the defense reaction (Maixner 1991), to pain sensitivity. Another stress-
relevant neuroendocrine factor that may modulate pain perception in humans, and which
constitutes the novel focus of this report, is Allopregnanalone (ALLO). ALLO is an A-ring-
reduced metabolite of progesterone that is produced by ovary and adrenals and also de novo
in brain (Paul & Purdy 1992). Owing to its lipophilicity, even peripherally produced ALLO
readily crosses into brain (Paul & Purdy 1992). ALLO is a potent modulator of GABAA
receptors via dose-dependent enhancement of GABA-induced Cl- ion channels (Morrow et al.
1987). ALLO is stress sensitive in both animals (Purdy et al. 1991;Barbaccia et al. 1996), and
humans (Girdler et al. 2001). Animal models indicate that stress-induced increases in ALLO
negatively modulate hypothalamic-pituitary-adrenal (HPA)-axis activity, thereby facilitating
the recovery of physiologic homeostasis in this system following stress (Guo et al.
1995;Patchev et al. 1996).
Stress-induced increases in ALLO may be adaptive since ALLO has analgesic properties when
administered in animals (Kavaliers & Wiebe 1987). Furthermore, animal models clearly
indicate the involvement of central GABAA receptors in modulating pain sensitivity (Yokoro
et al. 2001). To date, no studies have examined ALLO-associated analgesia in humans. The
primary aim of this report is to examine the relationship of ALLO to experimental pain
sensitivity in humans and determine whether ethnic differences are present. A secondary aim
of this report involves examining the inter-relationships of plasma cortisol and β-endorphin,
in the relationship of ALLO to pain sensitivity. To our knowledge, the relationship of β-
endorphin concentrations to pain sensitivity in different ethnic groups has not been studied.
METHODS
Subjects
Subjects that comprise the present report represent a large sub-sample of the participants
included in our recent report on ethnicity, pain sensitivity, and endogenous pain regulatory
mechanisms described above (Mechlin et al. 2005). While that prior study compared African
Americans with all ‘Other’ ethnic groups, given the evidence that Hispanic populations differ
in clinical pain systems (Hernandez & Sachs-Ericsson, 2006), the evidence for ethnic
differences between Asian Americans and European Americans in stress-responsive measures
(Stoney et al., 2002;Shen et al. 2004), and since the numbers of Hispanics (n = 2) and Asians
(n = 6) in our study did not allow for valid analyses, the present report compares African
Americans with non-Hispanic Whites only. Of the 107 subjects included in that earlier report,
we were able to analyze ALLO immunoreactivity (ALLO-ir) in plasma from 85 subjects who
self-reported as African American or non-Hispanic White. Thus, the present report represents
new measurements (ALLO and β-endorphin) in a large subset of those subjects on which we
previously reported.
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The participants were recruited through newspaper advertisements seeking male and female
nonsmokers for a study on pain perception. Non-smokers were recruited based on self-report.
Smokers were excluded since cigarette smoking has been shown to have analgesic properties
(Girdler et al. 2005). The sub-sample of subjects providing ALLO-ir samples was composed
of 41 men and 44 women, aged 18 - 47 years. Approximately half (n = 45) of the subjects was
African American (21 men, 24 women) while the other half (n = 39; 20 men, 19 women) was
non-Hispanic White.
There were no gender or ethnic group differences in age (range 18-47) or diastolic blood
pressure (DBP; range 50-87mmHg), or heart rate (range 50-92bpm). There were ethnic
differences in body mass index (BMI), since African Americans had higher BMIs than non-
Hispanic Whites (28.9 vs. 25.1; F(3, 82) = 7.92, p < .01). Also, men had higher resting systolic
blood pressure (SBP) than women (120mmHg vs. 112mmHg; F(3, 82) = 10.85, p < .01). No
ethnic × gender interactions were observed for any of the above biological measures.
All subjects were medically healthy, with no more than mildly elevated BP (< 160/90 mmHg)
as determined during an initial screening session. Only 4 subjects (2 non-Hispanic Whites and
2 African Americans) had elevated BP, defined as SBP > 135mmHg and/or DBP > 85mmHg.
Additionally, subjects were not taking any prescription medication, including oral
contraceptives or psychotropics, and none took any over-the-counter medication more than 4
times per month. Consistent with other studies on experimental pain (France et al. 2002;al’Absi
et al. 2004;Fillingim et al. 2005) we instructed subjects to refrain from using any analgesic or
other over-the-counter medications for 24 hours prior to pain testing. This was verified based
on self-report. All women reported regular menstrual cycles. Excluded from participating were
subjects with chronic pain conditions (e.g. temporomandibular joint disorder, fibromyalgia,
arthritis) and those exhibiting signs of depression or anxiety based on Hamilton rating scales
for depression (score > 7) and anxiety (> 9).
The protocol was approved by the institution’s Institutional Review Board and all subjects
provided informed, written consent prior to participating. Subjects received $150
compensation.
Procedures
Women were tested three times, once during the early follicular, once during the late follicular,
and once during the luteal phase of their menstrual cycles. Cycle phases were subsequently
confirmed using serum estradiol and progesterone concentrations. Men were also tested three
times, matched for number of days between test sessions. Since ALLO-ir levels are non-
detectable in a substantial proportion of women in their follicular phase (Girdler et al. 2001),
only luteal phase data are included in the present report. There were no significant differences
in the proportion of African American versus non-Hispanic White women whose luteal phase
session was the first test session (9 vs. 6, respectively), second test session (5 vs. 9), or last test
session (10 vs. 4; χ2(2) = 3.78, p = .15).
One goal of the larger parent study (Mechlin et al., 2005) was to examine stress-induced
analgesia (SIA). Thus, pain testing occurred twice; once following a modified Trier Social
Stress Test (TSST; Kirschbaum et al. 1993a,b, 1995a,b) and once following a time equivalent
rest control period. Half of the subjects received the rest condition first, while the other half
received the stress condition first. The order of stress first versus rest first was fully counter-
balanced within gender and ethnic groups. Analyses were limited to the pain sensitivity
measures obtained following the TSST (see Figure 1) since ALLO-ir and other neuroendocrine
factors were assessed during the extended baseline rest period that immediately preceded the
TSST. Since no blood samples were taken during the baseline period that preceded the rest
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control period, measures of pain sensitivity following the TSST were more temporally
contiguous with assessment of neuroendocrine factors.
For all subjects, lab testing began between 12pm and 2pm. An intravenous line (i.v.) was then
established in an arm vein and once in place, a curtain was drawn to hide the i.v. and arm, and
to minimize awareness of blood sampling.
The sequence of laboratory events was as follows (see Figure 1): 1) Instrumentation and
acclimation to the testing chamber; 2) i.v. set-up and recovery from venipuncture (10 min); 3)
Baseline (10 min quiet rest); 4) TSST (20 min); 5) Recovery (10 min); 6) Pain Testing; These
events are described fully below.
Baseline—Immediately following the i.v. setup, a 10 minute recovery from venipuncture
ensued, followed by a 10-minute baseline rest period. Blood was sampled at minute 10 of this
rest period for baseline ALLO-ir, cortisol and β-endorphin concentrations.
The Trier Social Stress Test (TSST) The TSST is a stress test that reliably induces large and
consistent HPA and cardiovascular responses (Kirschbaum et al.1993a,b, 1995a,b). The TSST
involved the following components (see Mechlin et al. 2005 for detailed description of stressor
events): 1) Pre-Task Instructions (5 min); 2) Speech Preparation Period (5 min); 3) Job Speech
(5 min); and 4) Paced Auditory Serial Addition Test (PASAT; Gronwall 1977) (8.5 min).
Stress Recovery (10 min)—Subjects rested quietly alone. Blood was also sampled for
stress-induced increases in cortisol and ALLO-ir at the end of this recovery period1.
Pain Testing Procedures Immediately after the recovery periods that followed the TSST,
subjects were exposed to the three different pain tests. One of three task orders (i.e., 1-
tourniquet, thermal, cold; 2- thermal, cold, tourniquet; or 3 - cold, tourniquet, thermal) was
randomly assigned to each subject, ensuring that equal numbers of men and women and African
Americans and non-Hispanic Whites received each of the three orders. There was a 5-minute
recovery period following each pain test.
The Submaximal Effort Tourniquet Procedure—In this procedure, as described
previously (Maixner et al. 1990), a tourniquet cuff was positioned on the subject’s arm and the
arm placed to the side. Prior to inflating the tourniquet cuff to 200 mmHg (Hokanson E20
Rapid Cuff Inflator), the subject’s arm was raised for 30 seconds to promote venous drainage,
and then the cuff was inflated, the experimenter’s stopwatch started, and the arm returned to
the side. To promote forearm ischemia, subjects engaged in 20 handgrip exercises at 30% of
their maximum force with an inter-squeeze interval of 2 sec. Subjects were instructed to
indicate when the sensations in their arm first became painful (pain threshold) and when they
were no longer willing or able to tolerate the pain (pain tolerance). A maximum time limit of
20 min was enforced, though subjects were not informed of this limit.
Hand Cold Pressor—The apparatus for the cold pressor consisted of a container filled with
ice and water that was maintained at 4° C as recorded immediately prior to initiating the test.
The use of a water circulator prevented the water from warming near the subject’s hand. At
the onset of the test, subjects were instructed to submerge their hand to the marked line on their
1Relationships involving ALLO-ir, cortisol, and pain sensitivity as a function of ethnicity did not differ in any appreciable way when
analyses were conducted using post-stress samples (post-stress samples of β-endorphin were not obtained). However, preliminary data
from our laboratory indicated that the post-stress sample obtained for ALLO-ir was delayed and did not capture the peak ALLO response
to stress (Girdler et al., unpublished data). Thus, in order to reduce further Type I error rates, to increase the generalizability of our findings
to the existing literature on neuroendocrine factors and pain perception, and because the ALLO response was not sampled when at peak
(Girdler et al. unpublished data), the present report focuses exclusively on the relationship of resting baseline samples to pain sensitivity.
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wrist and to remain still. Subjects were instructed to indicate to the experimenter when the
sensations in their hand first became painful (pain threshold) and to also indicate when they
were no longer willing or able to tolerate the pain by saying ‘stop’ (pain tolerance). A maximum
time limit of 5 min was imposed, though subjects were not informed of this limit.
Thermal Heat Pain Testing—Thermal heat pain threshold and tolerance were determined
by an ascending method of limits using a 1-cm diameter contact thermode with the capability
for a rise time of 10° C/ sec (Medoc TSA-II Neurosensory Analyzer). The thermode was
controlled by a personal computer, and thermal probe applied to the left volar forearm. During
the pain testing, an adapting temperature of 38° C was maintained for 10 sec. Then, the
temperature increased directly to 41.5° C and from that point on increased 0.5° C every 5 sec
until it reached 53° C or until the subject reached his/her tolerance. To determine thermal pain
onset (threshold), subjects were instructed to press a mouse button (which terminated the
stimulus) when the thermal percept first became painful. This was repeated three times and
averaged to calculate thermal pain thresholds. Then, three series to determine average thermal
pain tolerance were conducted by instructing the subject to press a mouse button when they
were no long able to tolerate the pain.
Hormone and Neuroendocrine Assays Plasma ALLO-ir (3α,5α-THP) was assessed by
radioimmunoassay (RIA) following extraction and purification by column chromatography as
previously described (Janis et al. 1998; Girdler et al. 2001). The 3α,5α-THP antiserum has
previously been shown to produce minimal cross reactivity with other circulating steroids
(Janis et al. 1998). Cross-reactivity with progesterone (<3%), as well as the stereochemical
isomers of 3α,5α-THP is minimal (3α,5β-THP 6.6%; 3β,5α-THP 2.8%; 3β,5β-THP 0.5%). In
contrast, the steroid 3α-hydroxy-4-pregnen-20-one binds to the antibody to a greater degree
than 3α,5α-THP (169% of 3α,5α-THP). It is unknown, however, whether 3α-hydroxy-4-
pregnen-20-one exists in human serum. If the steroid does exist in human serum, then it may
contribute to the measurement of ALLO; however, because both ALLO-ir and the pregnen-4
compound are equally efficacious agonists of GABAA receptor mediated Cl--uptake (Morrow
et al. 1990), they would be expected to produce similar effects. The intra- and inter-assay
coefficients of variation from the assay are 6.2% and 5.9% respectively.
Plasma cortisol was determined using RIA techniques (MP Biomedicals, Inc.). The intra- and
inter-assay coefficients of variation from the assay are 4.7% and 7.6%, respectively. The
sensitivity of the assay is 0.07 μg/dL, and the specificity high, showing 0.05-2.2% cross-
reactivity with most similar compounds.
Plasma β-endorphin was determined following extraction by RIA using a commercial kit
(INCSTAR Corp.). The intra- and inter-assay coefficients of variation from the assay are
approximately 10% and 15%, respectively, and the assay sensitivity is 3 pmol/L. There is less
than 0.01% cross-reactivity with most other peptides. Since β-endorphin is released in a
pulsatile manner, and therefore can vary greatly over time, β-endorphin concentrations were
averaged across all three test sessions, and this average β-endorphin concentration was used
in subsequent analyses.
Data Reduction and Analyses
Our first analytical strategy involved comparing groups for differences that existed in
demographic and baseline measures. For each dependent measure, a 2(Gender) × 2 (Ethnicity)
analysis of variance (ANOVA) was employed. Chi-square analyses were also employed where
indicated to examine ethnic differences in the proportion of subjects falling into various cells.
In order to investigate the relationship between ALLO and pain tolerance, as well as the
relationships involving β-endorphin, cortisol, and pain tolerance, a series of Pearson product
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moment correlational analyses were employed. Since our prior report (Mechlin et al. 2005)
documented that ethnic differences in pain sensitivity were evident in both genders, and since
ethnic differences existed only for measures of pain tolerance and not pain threshold, to reduce
Type I error rates our primary analyses focused exclusively on differences between African
Americans and non-Hispanic Whites, collapsing across gender though summary statistics by
gender are provided in Table 1.
Results revealed a significant order effect for sensitivity to the cold pressor task (F(1, 83) =
4.15, p < .05), since cold pressor tolerance was lowest for subjects who had the order thermal,
cold pressor, tourniquet (mean cold pressor tolerance = 19 sec; standard error of the mean
(SEM) = 2), compared with those who had the order cold pressor, tourniquet, and thermal
(mean cold pressor tolerance = 39 sec; SEM = 11), and those who had the order tourniquet,
thermal then cold pressor (mean cold pressor tolerance = 79 seconds; SEM = 20). Therefore,
order of pain testing was partialed out of all correlational analyses involving pain tolerance for
all three pain tasks, and was used as a covariate for all ANOVAs involving pain sensitivity.
Where significant inter-correlations involving ALLO-ir, pain tolerance and either cortisol or
β-endorphins emerged, we used the approach recommended by Baron and Kenny (1986),
including the Sobel test, which takes the standard error of regression coefficients into account,
and conducted mediational analyses to test whether the relationship between ALLO-ir and pain
tolerance was influenced by either cortisol or β-endorphin concentrations. This analysis
generates a student’s t value, an unstandardized regression coefficient (b) which is the value
of predicted change in the dependent variable given a one unit change in the independent
variable of interest when all other independent variables are held constant, and a standardized
regression coefficient (β) is similar to an unstandardized regression coefficient, however, since
it is standardized it allows for the comparison between independent variables of their relative
contribution to the dependent variable, for each variable in the model. Additionally, the
percentage of variance of the dependent variable accounted for by the independent variable
and mediator (R 2) is obtained, as well as a z-statistic from the Sobel test, which when
significant indicates that the mediator does in fact, carry an influence from the independent
variable to the dependent variable.
RESULTS
Baseline Characteristics
As summarized in Table 1, women in the luteal phase of their menstrual cycle had significantly
higher levels of ALLO-ir than men (F(1,82) = 119.12, p < .0001). Men had higher
concentrations of β-endorphin than women (F(1, 83) = 23.23, p < .0001). As previously
reported in the larger sample (Mechlin et al. 2005), overall the subset of men also had greater
cortisol concentrations than women (F(1,82) = 25.81, p < .0001), greater pain threshold (Fs(1,
82) = 2.51 to 7.63, ps < .05) and tolerance to all three pain tests (Fs(1, 82) = 4.94 to 12.13, ps
< .01) collapsing across ethnic groups (i.e. main effect of gender) even after controlling for
order of pain tests. Finally, as previously observed in the larger sample, African Americans
had lower tolerance values to all three pain tests relative to non-Hispanic Whites, and this was
true for both genders and after controlling for order (main effect of ethnicity: Fs(3, 92) = 3.32
to 10.53, ps< .05). There was no main effect of ethnicity on pain threshold for the thermal or
tourniquet tasks (Fs(2, 81) = 1.04 and 0.82, respectively), however there was a difference for
cold pressor pain threshold (F(2, 81) = 4.17, p < .01), with African Americans exhibiting a
lower pain threshold than non-Hispanic Whites.
For the cold pressor task, significantly more non-Hispanic White subjects than African
American subjects reached the 5-minute time limit (7 vs. 0; χ2(1) = 11.34, p < .01). There were
no ethnic differences in the proportion of subjects that reached the 20-minute time limit for the
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tourniquet task (3 vs. 6; χ2(1) = 1.75) or the 53°C limit for the thermal heat pain task (1 vs. 0;
χ2(1) = 1.19). When comparing subjects who had rest first vs. stress first, there were no
significant differences in thermal pain tolerance (48.4°C vs. 48.3°C, respectively), cold pressor
tolerance (62 seconds vs. 35 seconds), tourniquet pain tolerance (524 seconds vs. 426 seconds),
baseline ALLO-ir (0.91ng/mL vs. 0.85ng/mL), baseline cortisol (7.63pg/mL vs. 8.76pg/mL),
or baseline β-endorphin (7.96pg/mL vs. 7.49pg/mL). Therefore, subsequent analyses did not
control for the order of stress vs. rest.
Relationships Involving Neuroendocrine Factors and Pain Sensitivity
As summarized in Table 2, the only significant partial correlations (partialing out order of pain
tests) to emerge involving plasma ALLO-ir, β-endorphin or cortisol concentrations and pain
tolerance were seen in the non-Hispanic White subjects. ALLO-ir levels were negatively
correlated with thermal heat pain tolerance (r = -.47, p < .01), cold pressor pain tolerance (r =
-.35, p < .05), and ischemic pain tolerance (r = -.43, p < .01) in the non-Hispanic Whites. We
observed a positive partial correlation between plasma β-endorphin concentrations and cold
pressor tolerance levels (r = +.38, p<.05), but only in the non-Hispanic Whites, who also
showed the expected positive correlation between plasma cortisol and thermal heat pain
tolerance (r = +.39, p<.05) and cold pressor pain tolerance (r = +.32, p < .05). The partial
correlation coefficients relating ALLO-ir, β-endorphin, or cortisol concentrations to pain
tolerance were uniformly non-significant in the African Americans.
In non-Hispanic Whites, thermal heat pain threshold was significantly correlated with both
ALLO-ir (r = -.49, p < .01) and cortisol (r = +.50, p < .01), and ischemic pain threshold was
correlated with β-endorphin (r = +.37, p < .05). There were no significant partial correlations
involving pain threshold and biological measures in African Americans (rs = -.29 to +.24, ps
> .05).
As depicted in Table 3, the expected relationship between ALLO-ir concentrations and cortisol
concentrations (i.e., negative) was only significant in non-Hispanic Whites (r = -.50, p < .01;
see Figure 2), though the direction of the relationship was similar in the African Americans (r
= -.24; Figure 2), but it was not significant. Both groups showed negative correlations involving
ALLO-ir and β-endorphin concentrations (rs = -.44 and -.55, ps < .01; see Figure 3), while
neither group showed a statistically significant relationship involving plasma cortisol and β-
endorphin.
Mediational Analyses
Since only the non-Hispanic Whites showed significant correlations among ALLO-ir, cortisol,
β-endorphin, and pain tolerance, mediational analyses were conducted in that sample only
(Baron & Kenny 1986). Because baseline cortisol and β-endorphin were not correlated with
each other, they were not considered together in multiple mediation models but instead each
was examined as a simple mediator of the relationship between ALLO-ir and pain tolerance.
Despite the numerous intercorrelations between ALLO-ir, cortisol, β-endorphin, and pain
tolerance in non-Hispanic Whites, the only measure to meet strict criteria as a mediator in the
relationship between ALLO-ir and pain sensitivity was cortisol.
For non-Hispanic Whites, since baseline ALLO-ir was negatively correlated with baseline
cortisol (r = -.50, p < .01), and since both baseline ALLO-ir and baseline cortisol were correlated
with thermal heat pain threshold (rs = -.49 and +.50 respectively, ps < .01) ), a series of linear
regression analyses were performed (Baron & Kenny 1986) to test whether cortisol served as
a statistical mediator of the relationship between ALLO-ir and thermal heat pain threshold.
These analyses indicated that the significant regression coefficient relating baseline ALLO-ir
to thermal heat pain threshold (t = -2.85, p < .01; b = -1.72; β = -0.43; R2 = 0.16, p < .01) is
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reduced (t = -1.34, p > .05; b = -0.85; β = -0.21) and in fact no longer significant, when baseline
cortisol (t = 2.80, p < .01; b = 0.34; β = 0.44) is added to the model. Thus, higher baseline
concentrations of cortisol met criteria for mediating the relationship between lower baseline
ALLO-ir and higher thermal heat pain threshold (z = -2.18, p < .05). Baseline cortisol and
baseline ALLO-ir concentrations together accounted for 30% of the variance in thermal heat
pain tolerance (F(2, 35) = 8.74, p < .001).
When examining the relationship between ALLO-ir, cortisol, and thermal heat pain tolerance;
ALLO-ir, cortisol, and cold pressor pain tolerance; and ALLO-ir, β-endorphin, and cold pressor
pain tolerance, analyses indicated that cortisol did not meet statistical criteria as a mediator in
these relationships involving cortisol and pain sensitivity.
Discussion
The results of our study, which is the first to examine the relationship of plasma ALLO-ir
concentrations to pain sensitivity in humans, suggest that there may be ethnic differences in
the degree to which ALLO interacts with HPA-axis variables, cortisol and β-endorphin, to
influence pain perception.
Higher ALLO concentrations are associated with lower pain tolerance
Contrary to expectations, and inconsistent with animal studies showing that increased
concentrations of GABAergic neurosteroids, including ALLO-ir are associated with a
decrease in pain sensitivity (Kavaliers & Wiebe 1987), we found that higher ALLO-ir
concentrations were associated with increased pain sensitivity (lower pain tolerance), at least
in non-Hispanic Whites, and this was true for all three pain tests. One possibility for this
discrepancy is that in the animal models, animals are tested for pain sensitivity following the
administration of exogenous ALLO (Kavaliers & Wiebe 1987;Wiebe & Kavaliers 1988;Frye
& Duncan 1994), while our study examined the relationship of endogenous levels of ALLO-
ir and pain perception. Thus, the animal studies may have elicited supraphysiologic
concentrations of ALLO. Since there is evidence for a bimodal effect of ALLO concentration
on GABAA-regulated mood in humans (Miczek et al. 1993,1997,2003;Andréen et al. 2005),
we speculate that lower endogenous concentrations of ALLO, such as those seen during the
luteal phase, may be associated with enhanced sensitivity to pain, while higher concentrations
of ALLO, such as seen during pregnancy may be analgesic. Dose-response studies in humans
examining different ALLO-ir concentration profiles and pain sensitivity will be needed to test
this hypothesis.
The relationship between ALLO and pain sensitivity may be mediated by HPA-Axis Factors
Another, though not mutually exclusive possibility for finding an inverse relationship between
ALLO-ir concentrations and pain tolerance is indicated by our mediational analyses conducted
in the non-Hispanic Whites. A number of prior studies have shown that measures reflecting
increased activation of the HPA-axis, specifically higher plasma cortisol and higher plasma
β-endorphin concentrations, are related to reduced sensitivity to experimental pain procedures,
including cold pressor, ischemic, and thermal heat pain (al’Absi et al., 2002;Straneva et al.,
2002;Girdler et al., 2005;Mechlin et al., 2005). We also observed significant positive
correlations involving greater cortisol and β-endorphin concentrations and greater tolerance to
thermal heat and cold pressor pain in the non-Hispanic Whites.2 The results of our mediational
2It may be important to note that the relationship between baseline cortisol and increased thermal heat and cold pressor pain tolerance
in non-Hispanic Whites in the present report was not found in our prior report (Mechlin et al., 2005) from the larger sample. One distinct
possibility for this discrepancy concerns the influence of the menstrual cycle on the HPA-axis (Kirschbaum et al., 1999;Kowalczyk et
al., 2006) since all samples included in the present report came from women in the luteal phase of their menstrual cycle, while the prior
report, which focused on the first test session only, included women in various stages of their cycles.
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analyses extend the literature on HPA-axis activation and pain perception by providing the first
evidence in humans for an interrelationship between ALLO and cortisol to influence pain
sensitivity. Though we found that lower ALLO-ir concentrations were related to higher pain
tolerance to all three pain tests in non-Hispanic Whites, mediational analyses indicated that at
least for the thermal pain test, the inverse relationship was mediated by greater plasma cortisol.
While the exact mechanisms by which cortisol mediates the relationship between ALLO and
pain sensitivity are unknown, one possibility involves the negative modulation of the HPA-
axis by ALLO. Animal models demonstrate that increases in ALLO facilitate the return of
HPA-axis activation to homeostasis following stress (Guo et al. 1995;Patchev et al. 1996).
Activation of the HPA-axis with the associated pituitary release of β-endorphin and/or
increased corticotrophin-releasing hormone (CRH) activity, may be part of an integrated
adaptive mechanisms since both are associated with reduced pain sensitivity in humans
(Hargreaves et al. 1987;Rosa et al. 1988;Sheps et al., 1992;Lariviere & Melzack 2000;Straneva
et al. 2002). It is now well established that CRH acts on a large number of brain structures
involved in pain processing, including the locus coeruleus, and that it can act both centrally
and peripherally to produce analgesia (see Larivier & Melzack 2000 for review). Thus, since
ALLO and cortisol are negatively related (Girdler et al. 2001; Girdler et al. 2006), and ALLO
modulates the HPA-axis at multiple levels (Owens et al. 1992;Patchev et al. 1994;Patchev et
al. 1996;Calogero et al. 1998), higher circulating ALLO would be expected to be associated
with increased pain sensitivity as we documented in the non-Hispanic Whites. Regardless of
mechanism, ALLO-associated hyperalgesia in women could contribute to greater experimental
pain sensitivity when they are tested in their luteal versus follicular phase of the menstrual
cycle (Fillingim et al. 1997;Pfleeger et al. 1997;Riley et al. 1999).
Ethnic differences in the relationship of ALLO to pain sensitivity
Also regardless of mechanism, and in contrast to our findings in the non-Hispanic Whites, our
findings that significant interrelationships involving ALLO, cortisol, and pain sensitivity were
not observed in African Americans is consistent with our other finding from this same cohort
indicating ethnic differences in the relationship between pain sensitivity and stress-responsive
biological factors. We had previously suggested (Mechlin et al. 2005) that the ethnic
differences in the relationship involving plasma cortisol, NE, and BP and pain sensitivity may
contribute to the greater clinical pain severity (Mechlin et al. 2005) experienced by African
Americans. We have now extended those findings to include ethnic differences in the
relationships between both ALLO and β-endorphin and pain sensitivity. At the same time, it
must be acknowledged that many of the observed correlation coefficients in African Americans
involving pain tolerance and ALLO as well as the HPA-axis variables were similar in direction
to those observed in the non-Hispanic Whites, though they did not reach conventional levels
of significance (Table 2). While it is probable that these correlation coefficients would have
reached statistical significance if larger numbers of African Americans were included, low
statistical power to detect significant relationships cannot be the sole or even primary
explanation for the ethnic differences in the pattern of effects since our African American
sample was larger than the non-Hispanic White sample and there was no evidence for ethnic
differences in the variability of the neuroendocrine or pain sensitivity measures. Still, these
findings should be replicated in larger samples of African American and non-Hispanic Whites.
If confirmed, these results may have implications for the treatment of clinical pain in African
Americans.
Limitations
There are also several limitations of the study, which should be addressed. The primary
limitation to this report stems from the fact that the subjects represent a large subset of those
previously on which we previously reported, where we observed the absence of relationships
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involving plasma cortisol, NE, and BP and pain sensitivity in African Americans. Thus, while
the current report extends our observations to include the absence of relationships involving
plasma ALLO-ir and β-endorphin with pain sensitivity in African Americans, the possibility
exists that these findings are unique to this particular cohort of African Americans for whatever
reason. Replication of these general findings in other cohorts of African Americans will be
needed before any interpretations regarding ethnic differences in endogenous pain regulatory
mechanisms can or should be made. Second, we relied exclusively on baseline and not post-
stress samples and this may account for the unexpected inverse relationship we observed
between ALLO and pain tolerance in humans. Third, although the intercorrelations involving
ALLO-ir, cortisol, and β-endorphin were significant in the non-Hispanic Whites, the large
range of values, particularly for cortisol and β-endorphin, may limit the predictability of these
measures. Fourth, another limitation to our study relates to the use of laboratory testing
procedures to make inferences regarding clinical pain. For example, although both male and
female experimenters were randomly used, only non-White Hispanic experimenters
administered the pain tests. Although the effect of the experimenter’s ethnicity on pain
tolerance is equivocal (Zatzick & Dimsdale 1990;Weisse et al. 2005), the possibility does exist
that the ethnicity of the experimenter or other non-specific effects of a laboratory environment
could have influenced our findings. Finally, while one strength of our study was the use of
multiple pain tests, this strength was balanced by our finding of an order effect involving
sensitivity to the cold pressor test. Though we did statistically control for the order effects in
all analyses, the reason for these effects remain unexplained. Regardless of the reason for this
finding, it suggests the possibility for carryover effects from one procedure to another in human
clinical research that should be carefully conducted and controlled for in subsequent studies.
Conclusion
Despite the limitations to our study, the novel focus of the relationship of ALLO to pain
sensitivity in humans, and the interactions involving the HPA-axis are worth underscoring and
may serve as important early observations involving unfamiliar pain regulatory mechanisms
in humans. Our results suggest that lower physiologic concentrations of plasma ALLO are
associated with increased pain threshold and tolerance in non-Hispanic Whites, and that for
thermal heat pain threshold the relationship is mediated by higher cortisol concentrations. The
fact that we did not observe any significant relationships involving ALLO-ir, cortisol or β-
endorphins and pain sensitivity in African Americans adds to our prior report documenting
ethnic differences in the relationship of plasma NE, cortisol, and BP to pain sensitivity (Mechlin
et al. 2005), though, these findings need to be replicated in separate cohorts of African
Americans and non-Hispanic Whites.
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Figure 1. Overview of the Laboratory Testing Protocol
Schematic diagram representing the sequence of events during laboratory testing. Half of each
ethnic and gender group had the order of stress test and then rest control period as indicated
above (a followed by b), while the other half had rest control first (b followed by a).
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A scatterplot of the relationship between baseline levels of ALLO-ir and Cortisol separated by
ethnicity with non-Hispanic Whites displayed in the top panel, and African Americans
displayed in the bottom panel.
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A scatterplot of the relationship between baseline levels of ALLO-ir and β-endorphin with
non-Hispanic Whites displayed in the top panel, and African Americans displayed in the bottom
panel.
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Table 1
Mean (±SEM) Biological and Pain Sensitivity Measures as a Function of Ethnicity and Gender
African American
Females (n = 24)
Non-Hispanic
White Females (n =
19)
African American
Males (n = 21)
Non-Hispanic
White Males (n =
20)
Baseline ALLO (ng/mL) A 1.25 (0.08) 1.50 (0.10) 0.36 (0.09) 0.35 (0.09)
Baseline Cortisol (pg/mL)B 6.85 (0.67) 5.92 (0.75) 9.27 (0.72) 11.01 (0.73)
Baseline β-endorphin (pg/mL)B 6.47 (0.60) 5.84 (0.69) 9.61 (0.65) 9.00 (0.67)
Thermal Heat Threshold (°C) B 42.70 (0.59) 42.45 (0.69) 44.39 (0.64) 45.53 (0.65)
Thermal Heat Tolerance (°C) B, C 46.88 (0.37) 48.02 (0.44) 48. 47 (0.41) 50.26 (0.42)
Ischemic Threshold (sec) B 222 (51) 239 (62) 332 (56) 333 (59)
Ischemic Tolerance (sec) B, C 336 (67) 431 (78) 478 (73) 739 (75)
Cold Pressor Threshold (sec) B, C 6 (4) 10 (4) 12 (4) 28 (4)
Cold Pressor Tolerance (sec) B, C 12 (14) 42 (16) 25 (15) 121 (15)
A
Females > Males, p < .0001
B
Males > Females, p < .05
C
non-Hispanic Whites > African Americans, p < .01
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Table 3
Relationship of Neuroendocrine Factors as a Function of Ethnicity
African Americans (n = 45) Non-Hispanic Whites (n = 39)
Baseline ALLO Baseline Cortisol Baseline ALLO Baseline Cortisol
Baseline ALLO — r = -.24p = ns —
r = -.50**
p < .01
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